Order Article Reprints

Banerjee P, Wang Y, Carnevale LN, Patel P, Raspur CK, Tran N, Zhang X, Natarajan R, Roberts AJ, Baran PS, et al. diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer’s Disease. Antioxidants. 2025; 14(3):293. https://doi.org/10.3390/antiox14030293

Banerjee, Piu, Yubo Wang, Lauren N. Carnevale, Parth Patel, Charlene K Raspur, Nancy Tran, Xu Zhang, Ravi Natarajan, Amanda J. Roberts, Phil S. Baran, and et al. 2025. "diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer’s Disease" Antioxidants 14, no. 3: 293. https://doi.org/10.3390/antiox14030293

Banerjee, P., Wang, Y., Carnevale, L. N., Patel, P., Raspur, C. K., Tran, N., Zhang, X., Natarajan, R., Roberts, A. J., Baran, P. S., & Lipton, S. A. (2025). diAcCA, a Pro-Drug for Carnosic Acid That Activates the Nrf2 Transcriptional Pathway, Shows Efficacy in the 5xFAD Transgenic Mouse Model of Alzheimer’s Disease. Antioxidants, 14(3), 293. https://doi.org/10.3390/antiox14030293